Didascalia
: Sperimentazione in fase di reclutamento
= 
; Sperimentazione in corso
= 
-
- FRANCIA
- PROVENCE-ALPES-COTE D'AZUR
- MARSEILLE
- Study of the effect of Bi-001 (ascorbic acid) on muscle strength in patients with Charcot-Marie-Tooth 1 A (Phase II)
- CHU de Marseille - Hôpital de la Timone
- Centre de pharmacologie clinique et d'évaluation thérapeutique
- Ulteriori dettagli
-
- Trial randomizzato controllato multicentrico in doppio cieco con acido ascorbico verso placebo nel trattamento della malattia di Charcot-Marie-Tooth tipo 1A
- Fondazione IRCCS Istituto Neurologico "Carlo Besta"
- Clinica Neuropatie Degenerative Centrali e Periferiche
- Ulteriori dettagli
-
- PAESI BASSI
- Noord-Holland
- AMSTERDAM
- Ascorbic Acid Treatment in CMT1A Trial (AATIC) (Phase II)
- AMC - Academisch Medisch Centrum
- Afdeling Neurologie
- Ulteriori dettagli
-
- REGNO UNITO; GRAN BRETAGNA
- Greater London
- LONDON
- CMT-TRAUK: Randomised double blind placebo controlled trial of long term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (Phase III)
- National Hospital for Neurology and Neurosurgery
- MRC Centre for Neuromuscular Disease and Department of Molecular Neurosciences
- Ulteriori dettagli
